Felicia Flanigan
Chairman of the Board
BB Biotech AG
Germany
Biography
Dr. Silvia Schanz has been Director of Investor Relations of BB Biotech Inc. since 2012. She holds a Ph.D. in Biochemistry from the Swiss Federal Institute of Technology (ETH) Zurich and Master in Biochemistry, minor in Business Administration from the University Freiburg. Dr. Silvia Schanz has been Director of Investor Relations of BB Biotech Inc. since 2012. She holds a Ph.D. in Biochemistry from the Swiss Federal Institute of Technology (ETH) Zurich and Master in Biochemistry, minor in Business Administration from the University Freiburg.
Research Interest
Marketing
